Avai Bio (AVAI) Other financing activities (2020 - 2023)

Avai Bio has disclosed Other financing activities across 4 years of filings, most recently posting $588791.0 for Q4 2023.

• Other financing activities for Q4 2023 came in at $588791.0, up 254787.88% year-over-year; the trailing twelve-month figure through Dec 2023 was $613912.0 (up 212326.3% YoY), and the FY2023 annual result was $112014.0, changed N/A from the prior year.
• Other financing activities came in at $588791.0 for Q4 2023 at Avai Bio, up from $24890.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $588791.0 in Q4 2023 to a low of $15.0 in Q2 2021.
• The 4-year median for Other financing activities is $231.0 (2022), against an average of $122794.0.
• Peak annual rise in Other financing activities reached 254787.88% in 2023, while the deepest fall reached 254787.88% in 2023.
• Avai Bio's Other financing activities stood at $43.0 in 2020, then sank by 65.12% to $15.0 in 2021, then soared by 1440.0% to $231.0 in 2022, then surged by 254787.88% to $588791.0 in 2023.
• The last three Other financing activities figures came in at $588791.0 (Q4 2023), $24890.0 (Q1 2023), and $231.0 (Q4 2022), per Business Quant data.